2021. GLP-1 receptor agonist drugs as a protective factor against chronic kidney disease in patients with type 2 diabetes mellitus. Research, Society and Development. 10, 16 (Dec. 2021), e134101623517. DOI:https://doi.org/10.33448/rsd-v10i16.23517.